If you go forward one or one and a half years and count the number of AI IPO companies, China will actually be ahead. So overall, I think both countries have done well. We're seeing lots of great breakthroughs in healthcare. That same product could be extended to laboratory research, and, essentially, start to replace much of the work that laboratory technicians do. It has developed a robotic machine that can do Covid tests 100 times faster than without the machine because it's 24-7 with everything in parallel. It turns out that the laboratory is a great place for robotics.Īn example of one of the portfolio companies we’ve invested in is a company called MegaRobo. And that has led to AI-based drug discovery, protein folding, intelligent AI-based radiology, AI for social distancing, and the use of robotics in laboratories. That's kind of emergent and is beyond my predictions in “AI Superpowers” because Covid really accelerated a lot of that. Both countries have done a lot in AI for healthcare. Naturally, each will apply AI to areas that it's strong in. is stronger in enterprise software, and China is stronger in manufacturing. China has accelerated its robotics and manufacturing. is stronger in fundamental research, enterprise software and enterprise AI. Lee: Both countries have continued to become the “AI Superpowers” that I predicted, leading the world by far.
0 Comments
Leave a Reply. |